TREMFYA® (guselkumab)
TREMFYA® is a prescription medicine used for the treatment of moderately to severely active ulcerative colitis (UC) and moderately to severely active Crohn’s disease (CD).
You should NOT receive TREMFYA® if you have:
- Had an allergic reaction to Tremfya or any of its ingredients.
Before using TREMFYA®, tell your healthcare provider about all of your medical conditions, including if you:
- have any of the conditions or symptoms listed in the section “What is the most important information I should know about TREMFYA®?”
- have an infection that does not go away or that keeps coming back.
- have TB or have been in close contact with someone with TB.
- have recently received or are scheduled to receive an immunization (vaccine). You should avoid receiving live vaccines during treatment with TREMFYA®.
- are pregnant or plan to become pregnant. It is not known if TREMFYA® can harm your unborn baby.
- are breastfeeding or plan to breastfeed. It is not known if TREMFYA® passes into your breast milk.
Pregnancy Registry
If you become pregnant during treatment with TREMFYA®, talk to your healthcare provider about registering in the pregnancy exposure registry for TREMFYA®. You can enroll by visiting www.mothertobaby.org/ongoing-study/tremfya-guselkumab, by calling 1-877-311-8972, or emailing MotherToBaby@health.ucsd.edu. The purpose of this registry is to collect information about the safety of TREMFYA® during pregnancy.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
Infections
TREMFYA® may lower the ability of your immune system to fight infections and may increase your risk of infections. Your healthcare provider should check you for infections and tuberculosis (TB) before starting treatment with TREMFYA® and may treat you for TB before you begin treatment with TREMFYA® if you have a history of TB or have active TB. Your healthcare provider should watch you closely for signs and symptoms of TB during and after treatment with TREMFYA®.
Tell your healthcare provider right away if you have an infection or have symptoms of an infection, including:
|
|
What the Treatment Involves
TREMFYA® is given to a patient through an IV needle placed in the patient’s hand or arm. TREMFYA® is given over 1 hour. This is done in our infusion center where the patient can watch their electronic devices, read, or sleep while they are receiving their treatment.
TREMFYA® may cause serious side effects
- The most common side effects of TREMFYA®include: respiratory tract infections, headache, injection site reactions, joint pain (arthralgia), diarrhea, stomach flu (gastroenteritis), fungal skin infections, herpes simplex infections, stomach pain, and bronchitis.
- Liver problems can happen in people who receive TREMFYA® . Tell your healthcare provider right away if you have any of the following symptoms: tiredness, loss of appetite, pain on the right side of your abdomen, dark urine, or yellowing of the skin and eyes (jaundice).
- These are not all the possible side effects of TREMFYA®. Call your doctor for medical advice about side effects.
CO-Pay Program
TREMFYA® has a co-pay program can can help cover the costs of this medication if you have commercial insurance. Please ask our staff about signing up or visit the J&J website to get more information and/or sign up.
For complete information on TREMFYA®, please visit their website.
